Episode 181: Retina Clinic Efficiency and Logistics Panel with Dr. Amy Schefler, Dr. Chirag Shah, and Dr. Nathan Steinle

ay is joined by Dr. Amy Schefler, Dr. Chirag Shah, and Dr. Nathan Steinle for a panel discussion regarding how to best approach maximizing retina clinic efficiency and other issues new retina attendings in practice may encounter. You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio. Financial Disclosures: Dr. Sridhar: Consultant for Alcon, Alimera Sciences, and Thrombogenics. Dr. Schefler: Consultant for Allergan, Aura Biosciences, Castle Biosciences, Genentech, and Regeneron. Receives research support from Aura Biosciences, Castle Biosciences, Genentech, and Regeneron. Dr. Shah: Consultant for Regeneron. Receives research support from NIH, Alcon, Genentech, Novartis, Regeneron, Apellis, and Ellex. Dr. Steinle: Consultant for Apellis Pharmaceuticals, Alimera Sciences, Regeneron Pharmaceuticals, Genentech, Regenxbio, Carl Zeiss Meditec, Regenerative Patch Technologies, Novartis, and Vortex Surgery. Speaker’s Bureau for Alimera Sciences, Genentech, Regeneron Pharmaceuticals, NotalVision; and Novartis. Receives research support from Carl Zeiss Meditec, Genentech, Regeneron Pharmaceuticals, and Novartis. Investor in Vortex Surgical and Garbha Health.